Baird Medical Investment Holdings Ltd
BDMD Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$0.43
KIRA · Stoqly’s AI analyst, in plain words
- Baird Medical Investment Holdings Ltd had $22.5M of revenue in fiscal 2025, down 39.2% on the year before.
- Its operating margin was −113.7%, down 155.1 pts: of every 100 in sales, about −114 is left after running the business.
- Baird Medical Investment Holdings Ltd lost $27.3M in fiscal 2025.
- Free cash flow was −$1.4M in fiscal 2025, −6.2% of revenue.
- Baird Medical Investment Holdings Ltd owes $8.5M more than it holds in cash.
Market cap
$11.9M
P/E
—
Revenue
$22.5M
Net income
−$27.3M
Free cash flow
−$1.4M
Operating margin
−113.7%
Baird Medical Investment Holdings Ltd in 30 seconds · fiscal 2025
Are sales growing?
−39.2%
No. Sales fell 39.2% last year.
Does it make a profit?
−121.0%
No. It lost money last year.
Does profit turn into cash?
−6.2%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 9
Weak. It passes 1 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Baird Medical Investment Holdings Ltd does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 24, 2026
- Legal name
- Baird Medical Investment Holdings Ltd
- CIK
- 0001982444
Baird Medical Investment Holdings Ltd · BDMD
Results and finances
The last 4 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Sales and profit | ||||
| Revenue | $35.1M | $31.5M | $37.0M | $22.5M |
| Revenue growth | — | −10.4% | 17.7% | −39.2% |
| Gross margin | 79.9% | 86.6% | 88.2% | 83.8% |
| Operating margin | 38.8% | 37.7% | 41.4% | −113.7% |
| Net income | $12.8M | $10.5M | $12.5M | −$27.3M |
| Net margin | 36.4% | 33.5% | 33.6% | −121.0% |
| Diluted EPS | $0.49 | $0.51 | $0.57 | −$0.98 |
| Cash | ||||
| Cash from operations | $0.5M | −$1.0M | −$6.3M | −$1.3M |
| Capital expenditure | $5.9M | $2.6M | $2.9M | $0.0M |
| Free cash flow | −$5.4M | −$3.7M | −$9.2M | −$1.4M |
| FCF margin | −15.5% | −11.6% | −24.8% | −6.2% |
| Share count change | — | −19.4% | 6.0% | 27.3% |
| Debt and strength | ||||
| Cash and short-term investments | $1.7M | $1.5M | $3.0M | $0.2M |
| Debt incl. finance leases | — | $2.4M | $4.5M | $8.7M |
| Shareholders' equity | $25.8M | $35.8M | $39.7M | $31.4M |
| Net debt / EBITDA | — | 0.1x | 0.1x | — |
| Current ratio | — | 2.1x | 1.8x | 1.7x |
| Interest coverage | 45.5x | 41.7x | 26.6x | −34.8x |
| Returns and quality | ||||
| Return on capital | — | 27.9% | 33.3% | −50.7% |
| Return on equity | 49.6% | 34.3% | 33.0% | −76.8% |
| Return on tangible equity | 48.8% | 29.6% | 31.5% | −87.2% |
| Piotroski F-score | — | — | 2 | 1 |
| Altman Z'' | — | 6.5 | 5.8 | 0.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Baird Medical Investment Holdings Ltd · BDMD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.43 a share, the company is worth $11.9M.
Source: SEC EDGAR XBRL filings (CIK 0001982444). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.